Related references
Note: Only part of the references are listed.14q32-encoded microRNAs mediate an oligometastatic phenotype
Abhineet Uppal et al.
ONCOTARGET (2015)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Mirjam C. Boelens et al.
CELL (2014)
The Association of CXCR3 and Renal Cell Carcinoma Metastasis
Takanobu Utsumi et al.
JOURNAL OF UROLOGY (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
HyeonJoo Cheon et al.
EMBO JOURNAL (2013)
The role of CXCR3 and CXCR4 in colorectal cancer metastasis
Teppei Murakami et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
D. W. Kufe
ONCOGENE (2013)
CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis
Jong-Ho Lee et al.
CANCER RESEARCH (2012)
Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth
Nikolai N. Khodarev et al.
CLINICAL CANCER RESEARCH (2012)
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion
Qian Wu et al.
MOLECULAR CANCER (2012)
Expression Signature of IFN/STAT1 Signaling Genes Predicts Poor Survival Outcome in Glioblastoma Multiforme in a Subtype-Specific Manner
Christine W. Duarte et al.
PLOS ONE (2012)
CXCL10 reduces melanoma proliferation and invasiveness in vitro and in vivo
F. Antonicelli et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
CXCR3 ligands: redundant, collaborative and antagonistic functions
Joanna R. Groom et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
The Functions of Signal Transducers and Activators of Transcriptions 1 and 3 as Cytokine-Inducible Proteins
HyeonJoo Cheon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas
Blanche Ka Ki Lo et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth
Julia Schultz et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma
Lynn T. Dengel et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
N. Khodarev et al.
ONCOGENE (2010)
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
B. Cambien et al.
BRITISH JOURNAL OF CANCER (2009)
MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer
Nikolai N. Khodarev et al.
CANCER RESEARCH (2009)
Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells-Significant Roles of CXCL10
Mitsugu Fujita et al.
CANCER RESEARCH (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
Xinrong Ma et al.
MOLECULAR CANCER THERAPEUTICS (2009)
STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy
Nikolai N. Khodarev et al.
PLOS ONE (2009)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
K. Kawada et al.
ONCOGENE (2007)
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
C. Monteagudo et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
Adi Zipin-Roitman et al.
CANCER RESEARCH (2007)
CXC chemokine ligand 9/monokine induced by IFN-γ production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors
Anton V. Gorbachev et al.
JOURNAL OF IMMUNOLOGY (2007)
Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer
Tonya C. Walser et al.
CANCER RESEARCH (2006)
Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma
K Jöhrer et al.
CLINICAL CANCER RESEARCH (2005)
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells
NN Khodarev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
K Kawada et al.
CANCER RESEARCH (2004)
Structure-function relationship between the human chemokine receptor CXCR3 and its ligands
I Clark-Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes
A Bonacchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
